PALO ALTO, Calif., July 14, 2020 /PRNewswire/ — Genobank.io, the first ever anonymous, privacy-preserving DNA extraction kit announced that it has reached $418,000 in crowdfunding from over 1,400 investors around the world. The crowdfunding opportu… […]
SAN CARLOS, Calif., July 14, 2020 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, has received the Force for Change Illuminator award from LWE, accepted by Sheetal Parmar, Natera’s VP of Medical Aff… […]
High content screen identifies fostamatinib as a candidate for repurposing for Acute Lung Injury
SOUTH SAN FRANCISCO, Calif., July 14, 2020 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the initiation of an investigator-s… […]
SOUTH SAN FRANCISCO, Calif., July 14, 2020 /PRNewswire/ — IDEAYA Biosciences, Inc. (Nasdaq: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, announced the Company will parti… […]
– Strong anti-VEGF safety, efficacy and durability continue to be observed across all three of the major retinal vascular diseases, with most patients achieving treatment-free intervals of 6-months in wet AMD, 6-months or longer in DME, and 4-months o… […]
SAN JOSE, Calif., July 10, 2020 /PRNewswire/ — Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that the European Patent Office has issued an … […]
TAVLESSE initial launch in Germany and the U.K. by Grifols S.A.
SOUTH SAN FRANCISCO, Calif., July 9, 2020 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Grifols S.A., its collaborative partner in Europe, has launched … […]
SAN MATEO, Calif., July 9, 2020 /PRNewswire/ — NuMedii, Inc., a data-driven drug discovery company, today announced the availability of the world’s first single-cell sequencing atlas for idiopathic pulmonary fibrosis (IPF) that was the result of a … […]
SOUTH SAN FRANCISCO, Calif., July 9, 2020 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, announced First-Patient-In (FPI) in… […]
SAN FRANCISCO, July 8, 2020 /PRNewswire/ — ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management solutions, today announced that a fast growing research based biopharmaceutical company has chosen the ValGenesis Validation … […]
Copyright © 2020 | MH Magazine WordPress Theme by MH Themes
